March 26, 2018 / 11:52 AM / 8 months ago

BRIEF-Acorda Files Marketing Authorization Application For Inbrija

1 Min Read

March 26 (Reuters) - Acorda Therapeutics Inc:

* ACORDA FILES MARKETING AUTHORIZATION APPLICATION FOR INBRIJA™ (LEVODOPA INHALATION POWDER)

* ACORDA THERAPEUTICS INC - ‍ACORDA IS SEEKING MARKETING APPROVAL IN EUROPEAN UNION FOR INBRIJA​

* ACORDA THERAPEUTICS INC - ‍U.SFDA IS CURRENTLY REVIEWING A NEW DRUG APPLICATION FOR INBRIJA AND HAS SET AN ACTION DATE OF OCT 5, 2018 UNDER PDUFA​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.